Filing metadata

Accession number
0001104659-21-048255
Form type
Form 4
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Apr 08, 2021
Reporting period
Feb 06, 2021
Description
Insider transaction

Explore SEC Filings Hub